Effectiveness of the Intraligamentary Anesthesia and Inferior Alveolar Nerve Block on Pain During Dental Treatment
Launched by UNIVERSITY MEDICINE GREIFSWALD · Sep 18, 2020
Trial Information
Current as of May 23, 2025
Completed
Keywords
ClinConnect Summary
MATERIALS AND METHODS This prospective randomized comparative clinical trial was conducted in the integrated clinical course in the dental school of the University of Greifswald, Germany after the approval of the local ethics committee of the medical faculty in Greifswald (No. BB 174/18) in a period from December 2018 to June 2019. The sample size calculation using "G\*power version 3.1" (Heinrich-Heine-University / Germany) was based on the following estimates: T-test for means (difference between two independent means), effect size 0.7, α error 0.05 and power (1-ß error) 0.9. It resulted ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • patients requiring regular dental in permanent mandibular posterior teeth under local anesthesia
- Exclusion Criteria:
- • Patients with a clinical or radiographic sign of acute abscess, pus or peri-radicular pathology
- • Patients with a systemic disease requiring special considerations during their dental treatment
- • Patients with contra-indications for any of the components of the anesthetic solution (allergy to articaine, epinephrine, and sulfite)
About University Medicine Greifswald
University Medicine Greifswald is a prominent academic medical center located in Greifswald, Germany, dedicated to advancing healthcare through innovative research and clinical excellence. As a clinical trial sponsor, it fosters a collaborative environment that integrates cutting-edge scientific inquiry with patient care, focusing on a wide range of medical disciplines. The institution is committed to enhancing patient outcomes by conducting rigorous clinical trials that adhere to the highest ethical standards and regulatory requirements. With a strong emphasis on interdisciplinary collaboration, University Medicine Greifswald aims to contribute significantly to the development of new therapies and medical advancements, ultimately improving healthcare delivery and patient well-being.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Greifswald, , Germany
Patients applied
Trial Officials
Christian splieth, PHD
Study Director
University Medicine of Greifswald
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials